AI-assisted immune profiling helps predict treatment success in rectal cancer patients

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers at UCL and UCLH.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup